Effects of finerenone versus SGLT2 inhibitors on cardiovascular events in patients with type 2 diabetes mellitus and/or chronic kidney disease

Wang Xia, Zhang Lingyun, Song Shoujun, Xu Hongxin
International Medicine and Health Guidance News . 2024, (5): 781 -788 .  DOI: 10.3760/cma.j.issn.1007-1245.2024.05.016